- Home
- CRDF vs RMM Comparison
CRDF vs RMM Comparison
Compare CRDF & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- RMM
- Stock Information
- Founded
- CRDF 1999
- RMM 2019
- Country
- CRDF United States
- RMM United States
- Employees
- CRDF N/A
- RMM N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- RMM Trusts Except Educational Religious and Charitable
- Sector
- CRDF Health Care
- RMM Finance
- Exchange
- CRDF Nasdaq
- RMM Nasdaq
- Market Cap
- CRDF 210.2M
- RMM 271.2M
- IPO Year
- CRDF N/A
- RMM N/A
- Fundamental
- Price
- CRDF $3.17
- RMM $13.41
- Analyst Decision
- CRDF Strong Buy
- RMM
- Analyst Count
- CRDF 5
- RMM 0
- Target Price
- CRDF $10.50
- RMM N/A
- AVG Volume (30 Days)
- CRDF 1.4M
- RMM 66.5K
- Earning Date
- CRDF 08-07-2025
- RMM 01-01-0001
- Dividend Yield
- CRDF N/A
- RMM 7.33%
- EPS Growth
- CRDF N/A
- RMM N/A
- EPS
- CRDF N/A
- RMM 0.96
- Revenue
- CRDF $587,000.00
- RMM N/A
- Revenue This Year
- CRDF N/A
- RMM N/A
- Revenue Next Year
- CRDF N/A
- RMM N/A
- P/E Ratio
- CRDF N/A
- RMM $15.55
- Revenue Growth
- CRDF N/A
- RMM N/A
- 52 Week Low
- CRDF $2.01
- RMM $12.32
- 52 Week High
- CRDF $5.64
- RMM $16.10
- Technical
- Relative Strength Index (RSI)
- CRDF 45.05
- RMM 33.01
- Support Level
- CRDF $2.96
- RMM $13.34
- Resistance Level
- CRDF $3.24
- RMM $13.49
- Average True Range (ATR)
- CRDF 0.28
- RMM 0.10
- MACD
- CRDF -0.10
- RMM -0.02
- Stochastic Oscillator
- CRDF 14.08
- RMM 4.11
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.